Project
avrg: GSE58827: Dynamics of the Mouse Liver
Navigation
Downloads
Results for Tfdp1_Wt1_Egr2
Z-value: 5.02
Motif logo
Transcription factors associated with Tfdp1_Wt1_Egr2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
Tfdp1
|
ENSMUSG00000038482.12 | Tfdp1 |
|
Wt1
|
ENSMUSG00000016458.16 | Wt1 |
|
Egr2
|
ENSMUSG00000037868.16 | Egr2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Tfdp1 | mm39_v1_chr8_+_13389656_13389674 | 0.92 | 1.6e-15 | Click! |
| Wt1 | mm39_v1_chr2_+_104961228_104961326 | 0.62 | 5.4e-05 | Click! |
| Egr2 | mm39_v1_chr10_+_67373691_67373760 | 0.46 | 4.5e-03 | Click! |
Activity profile of Tfdp1_Wt1_Egr2 motif
Sorted Z-values of Tfdp1_Wt1_Egr2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of Tfdp1_Wt1_Egr2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.5 | 42.6 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 7.7 | 23.1 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
| 6.9 | 20.8 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
| 6.6 | 19.7 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 6.5 | 19.6 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
| 6.2 | 24.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 6.1 | 73.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 5.9 | 41.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 5.7 | 5.7 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 5.6 | 16.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 5.4 | 16.1 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
| 5.2 | 15.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 5.2 | 26.1 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 5.2 | 20.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 5.1 | 20.3 | GO:0010286 | heat acclimation(GO:0010286) |
| 4.8 | 19.1 | GO:0031662 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 4.3 | 13.0 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 4.3 | 4.3 | GO:0001966 | thigmotaxis(GO:0001966) |
| 4.3 | 17.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 4.3 | 17.1 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 4.2 | 16.9 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 4.2 | 8.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 4.1 | 20.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 4.1 | 40.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
| 4.0 | 12.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 3.9 | 42.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 3.9 | 3.9 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 3.8 | 42.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 3.8 | 15.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 3.8 | 22.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 3.7 | 18.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 3.5 | 10.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 3.4 | 27.5 | GO:0032796 | uropod organization(GO:0032796) |
| 3.4 | 30.9 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 3.4 | 3.4 | GO:0070194 | synaptonemal complex disassembly(GO:0070194) |
| 3.4 | 10.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
| 3.3 | 20.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 3.3 | 19.9 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 3.3 | 3.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 3.2 | 16.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 3.1 | 25.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 3.0 | 12.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 3.0 | 12.0 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 3.0 | 35.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 3.0 | 8.9 | GO:0072708 | response to sorbitol(GO:0072708) |
| 2.9 | 29.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 2.9 | 8.6 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 2.9 | 8.6 | GO:0030221 | basophil differentiation(GO:0030221) |
| 2.8 | 11.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 2.8 | 8.3 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 2.7 | 5.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 2.7 | 19.0 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 2.7 | 27.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 2.7 | 24.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.7 | 16.1 | GO:0030421 | defecation(GO:0030421) |
| 2.6 | 10.6 | GO:0003017 | lymph circulation(GO:0003017) |
| 2.6 | 10.6 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
| 2.5 | 2.5 | GO:0035844 | cloaca development(GO:0035844) |
| 2.5 | 29.7 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 2.5 | 7.4 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
| 2.5 | 7.4 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 2.5 | 9.8 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 2.5 | 12.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 2.5 | 7.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.4 | 4.9 | GO:0014737 | positive regulation of muscle atrophy(GO:0014737) |
| 2.4 | 19.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 2.4 | 9.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 2.4 | 9.5 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 2.4 | 9.4 | GO:0006272 | leading strand elongation(GO:0006272) |
| 2.4 | 16.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 2.3 | 2.3 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
| 2.3 | 7.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
| 2.3 | 23.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 2.3 | 27.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 2.3 | 6.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 2.2 | 11.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 2.2 | 2.2 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 2.2 | 4.4 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 2.2 | 6.6 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 2.2 | 6.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 2.2 | 6.5 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 2.1 | 14.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 2.1 | 8.5 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 2.1 | 6.3 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 2.1 | 6.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 2.1 | 6.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 2.1 | 8.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 2.0 | 8.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 2.0 | 4.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 2.0 | 4.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 2.0 | 6.1 | GO:0015825 | L-serine transport(GO:0015825) |
| 2.0 | 14.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 2.0 | 2.0 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 2.0 | 8.0 | GO:1902896 | terminal web assembly(GO:1902896) |
| 2.0 | 8.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 2.0 | 68.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 2.0 | 2.0 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 2.0 | 2.0 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 1.9 | 5.8 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 1.9 | 5.8 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 1.9 | 15.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.9 | 44.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 1.9 | 32.2 | GO:0033280 | response to vitamin D(GO:0033280) |
| 1.9 | 5.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.9 | 9.4 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 1.9 | 1.9 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 1.9 | 3.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.8 | 7.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 1.8 | 5.5 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 1.8 | 1.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
| 1.8 | 12.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 1.8 | 3.6 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
| 1.8 | 61.5 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 1.8 | 5.4 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.8 | 7.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 1.8 | 9.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.8 | 5.4 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 1.8 | 3.6 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.8 | 10.8 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
| 1.8 | 16.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 1.8 | 5.3 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
| 1.7 | 5.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 1.7 | 19.1 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 1.7 | 13.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 1.7 | 10.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.7 | 28.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 1.7 | 13.6 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 1.7 | 18.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.7 | 11.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 1.7 | 16.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 1.7 | 13.4 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.7 | 3.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 1.7 | 15.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 1.7 | 6.7 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 1.7 | 1.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 1.6 | 3.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 1.6 | 11.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 1.6 | 14.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 1.6 | 3.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
| 1.6 | 1.6 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 1.6 | 4.8 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
| 1.6 | 27.0 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.6 | 11.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 1.6 | 6.3 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
| 1.6 | 7.8 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 1.6 | 4.7 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
| 1.6 | 1.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 1.6 | 10.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.5 | 4.6 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 1.5 | 4.6 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 1.5 | 1.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 1.5 | 19.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 1.5 | 1.5 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 1.5 | 4.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
| 1.5 | 54.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 1.5 | 9.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 1.5 | 12.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 1.5 | 13.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 1.5 | 24.0 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.5 | 4.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.5 | 7.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 1.5 | 20.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
| 1.5 | 9.0 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 1.5 | 4.5 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.5 | 1.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 1.5 | 5.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 1.5 | 4.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 1.4 | 1.4 | GO:0033864 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 1.4 | 14.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 1.4 | 20.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 1.4 | 7.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 1.4 | 4.3 | GO:1904172 | positive regulation of bleb assembly(GO:1904172) |
| 1.4 | 7.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 1.4 | 1.4 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 1.4 | 1.4 | GO:1904464 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
| 1.4 | 7.1 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 1.4 | 7.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 1.4 | 2.8 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 1.4 | 11.2 | GO:0015675 | nickel cation transport(GO:0015675) |
| 1.4 | 12.6 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.4 | 2.8 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 1.4 | 5.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 1.4 | 2.7 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 1.4 | 24.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 1.4 | 40.5 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 1.3 | 8.1 | GO:0015871 | choline transport(GO:0015871) |
| 1.3 | 57.2 | GO:0006284 | base-excision repair(GO:0006284) |
| 1.3 | 5.3 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 1.3 | 4.0 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.3 | 10.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 1.3 | 5.3 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 1.3 | 6.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 1.3 | 5.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.3 | 6.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 1.3 | 6.5 | GO:1904170 | regulation of bleb assembly(GO:1904170) negative regulation of bleb assembly(GO:1904171) |
| 1.3 | 5.2 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 1.3 | 20.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 1.3 | 6.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.3 | 6.5 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
| 1.3 | 3.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 1.3 | 15.5 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 1.3 | 7.7 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.3 | 11.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 1.3 | 1.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 1.3 | 5.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.3 | 7.6 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.3 | 3.8 | GO:0071047 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 1.3 | 1.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 1.2 | 9.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 1.2 | 7.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 1.2 | 11.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 1.2 | 3.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 1.2 | 3.7 | GO:1990428 | miRNA transport(GO:1990428) |
| 1.2 | 4.9 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.2 | 4.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 1.2 | 7.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 1.2 | 6.1 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 1.2 | 6.0 | GO:0044849 | estrous cycle(GO:0044849) |
| 1.2 | 2.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.2 | 4.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.2 | 5.9 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 1.2 | 28.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 1.2 | 16.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 1.2 | 3.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
| 1.2 | 7.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 1.2 | 1.2 | GO:0061511 | centriole elongation(GO:0061511) |
| 1.2 | 4.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 1.2 | 2.3 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 1.2 | 5.8 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 1.2 | 3.5 | GO:0098749 | cerebellar neuron development(GO:0098749) |
| 1.2 | 9.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 1.2 | 3.5 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 1.2 | 19.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 1.2 | 3.5 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 1.2 | 6.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 1.2 | 13.9 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 1.2 | 1.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 1.2 | 2.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.1 | 4.6 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 1.1 | 6.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 1.1 | 4.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 1.1 | 4.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.1 | 3.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.1 | 2.3 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 1.1 | 5.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 1.1 | 4.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 1.1 | 10.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 1.1 | 1.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 1.1 | 5.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 1.1 | 6.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 1.1 | 1.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 1.1 | 3.3 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 1.1 | 8.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.1 | 10.8 | GO:0008228 | opsonization(GO:0008228) |
| 1.1 | 14.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 1.1 | 13.0 | GO:0051014 | actin filament severing(GO:0051014) |
| 1.1 | 34.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 1.1 | 19.4 | GO:0015816 | glycine transport(GO:0015816) |
| 1.1 | 3.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.1 | 6.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 1.1 | 1.1 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.1 | 11.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.1 | 5.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.1 | 3.2 | GO:0006233 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
| 1.1 | 34.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 1.1 | 2.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 1.1 | 3.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 1.1 | 19.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 1.1 | 12.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 1.1 | 3.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.1 | 34.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 1.0 | 24.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 1.0 | 2.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 1.0 | 5.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.0 | 5.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 1.0 | 7.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 1.0 | 11.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.0 | 3.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 1.0 | 5.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.0 | 3.1 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 1.0 | 5.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 1.0 | 10.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 1.0 | 3.1 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
| 1.0 | 3.1 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 1.0 | 1.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 1.0 | 4.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 1.0 | 17.3 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
| 1.0 | 2.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 1.0 | 11.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 1.0 | 20.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 1.0 | 9.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 1.0 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 1.0 | 9.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 1.0 | 5.0 | GO:0007412 | axon target recognition(GO:0007412) |
| 1.0 | 2.0 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 1.0 | 2.9 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 1.0 | 15.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.0 | 2.9 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 1.0 | 1.0 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.0 | 5.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 1.0 | 15.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 1.0 | 4.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 1.0 | 2.9 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.9 | 4.7 | GO:0009597 | detection of virus(GO:0009597) |
| 0.9 | 1.9 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.9 | 1.9 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.9 | 2.8 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.9 | 14.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.9 | 2.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.9 | 2.8 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.9 | 2.8 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.9 | 9.3 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
| 0.9 | 0.9 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.9 | 1.9 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.9 | 2.8 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
| 0.9 | 9.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.9 | 8.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.9 | 1.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.9 | 4.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.9 | 0.9 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.9 | 3.7 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.9 | 1.8 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.9 | 4.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.9 | 0.9 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.9 | 1.8 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
| 0.9 | 2.7 | GO:0035934 | corticosterone secretion(GO:0035934) |
| 0.9 | 4.5 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.9 | 26.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.9 | 0.9 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
| 0.9 | 2.7 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
| 0.9 | 0.9 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.9 | 20.3 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.9 | 2.7 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.9 | 6.2 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.9 | 0.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.9 | 14.0 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.9 | 1.8 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.9 | 24.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.9 | 2.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.9 | 14.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
| 0.9 | 10.4 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
| 0.9 | 3.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.9 | 1.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.9 | 0.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.9 | 4.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 0.9 | 4.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.8 | 3.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.8 | 15.3 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.8 | 3.4 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
| 0.8 | 6.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.8 | 8.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.8 | 1.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
| 0.8 | 3.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.8 | 4.2 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.8 | 12.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.8 | 3.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.8 | 10.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.8 | 3.3 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.8 | 2.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
| 0.8 | 1.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 0.8 | 5.7 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 0.8 | 4.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.8 | 4.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.8 | 8.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.8 | 0.8 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.8 | 4.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.8 | 32.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
| 0.8 | 3.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.8 | 3.2 | GO:0015904 | tetracycline transport(GO:0015904) |
| 0.8 | 6.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.8 | 3.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.8 | 4.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.8 | 8.8 | GO:0015074 | DNA integration(GO:0015074) |
| 0.8 | 11.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.8 | 2.4 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
| 0.8 | 7.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.8 | 44.6 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.8 | 0.8 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.8 | 2.3 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.8 | 16.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.8 | 2.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.8 | 1.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.8 | 6.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.8 | 0.8 | GO:0060956 | stem cell fate specification(GO:0048866) endocardial cell differentiation(GO:0060956) |
| 0.8 | 2.3 | GO:0097045 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.8 | 0.8 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 0.8 | 0.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.8 | 4.6 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.8 | 1.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.8 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.8 | 4.5 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.8 | 0.8 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.8 | 7.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.7 | 3.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.7 | 3.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.7 | 4.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 0.7 | 13.5 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.7 | 7.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.7 | 31.2 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.7 | 1.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.7 | 8.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.7 | 1.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.7 | 1.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.7 | 0.7 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.7 | 17.0 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.7 | 1.5 | GO:1902946 | protein localization to early endosome(GO:1902946) |
| 0.7 | 4.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.7 | 3.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.7 | 11.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.7 | 10.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.7 | 1.5 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.7 | 2.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.7 | 0.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
| 0.7 | 16.5 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
| 0.7 | 5.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.7 | 1.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.7 | 1.4 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 0.7 | 5.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.7 | 5.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.7 | 1.4 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.7 | 11.4 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.7 | 2.1 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.7 | 14.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.7 | 4.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.7 | 1.4 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.7 | 3.5 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.7 | 1.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
| 0.7 | 11.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.7 | 1.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.7 | 9.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.7 | 1.4 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.7 | 2.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.7 | 5.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.7 | 0.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.7 | 2.7 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.7 | 2.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.7 | 65.8 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.7 | 4.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.7 | 22.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.7 | 2.0 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.7 | 7.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.7 | 2.0 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
| 0.7 | 2.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.7 | 2.0 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.7 | 2.0 | GO:0031104 | dendrite regeneration(GO:0031104) |
| 0.7 | 5.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.7 | 2.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.7 | 8.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.7 | 15.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.7 | 1.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.6 | 3.2 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.6 | 1.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.6 | 1.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.6 | 3.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.6 | 2.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.6 | 2.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.6 | 0.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.6 | 1.9 | GO:0046084 | adenine salvage(GO:0006168) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.6 | 3.8 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.6 | 3.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.6 | 1.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.6 | 3.2 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.6 | 0.6 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
| 0.6 | 1.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.6 | 3.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.6 | 5.0 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.6 | 5.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
| 0.6 | 5.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.6 | 6.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
| 0.6 | 0.6 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.6 | 5.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.6 | 2.5 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.6 | 1.9 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.6 | 8.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.6 | 0.6 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.6 | 6.8 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.6 | 1.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.6 | 5.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.6 | 2.4 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.6 | 1.2 | GO:0072104 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 | 4.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.6 | 29.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.6 | 7.9 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.6 | 2.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.6 | 4.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.6 | 3.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.6 | 0.6 | GO:0051595 | response to methylglyoxal(GO:0051595) |
| 0.6 | 4.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.6 | 2.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.6 | 0.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.6 | 7.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.6 | 2.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.6 | 7.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.6 | 3.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.6 | 0.6 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.6 | 39.9 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.6 | 3.4 | GO:0051383 | kinetochore organization(GO:0051383) |
| 0.6 | 1.1 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
| 0.6 | 9.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.6 | 36.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.6 | 2.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.6 | 10.7 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.6 | 0.6 | GO:2000409 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
| 0.6 | 2.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.6 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.6 | 2.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.6 | 1.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.6 | 3.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.6 | 1.7 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.6 | 2.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.6 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.5 | 7.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.5 | 4.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.5 | 0.5 | GO:2000156 | regulation of retrograde vesicle-mediated transport, Golgi to ER(GO:2000156) |
| 0.5 | 9.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.5 | 1.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.5 | 3.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.5 | 1.6 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.5 | 1.6 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.5 | 1.6 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.5 | 2.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.5 | 4.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.5 | 2.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.5 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.5 | 1.6 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.5 | 2.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.5 | 2.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.5 | 2.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.5 | 3.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 | 2.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.5 | 2.6 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.5 | 6.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.5 | 1.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.5 | 2.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.5 | 2.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.5 | 1.5 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
| 0.5 | 1.0 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.5 | 0.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
| 0.5 | 1.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.5 | 4.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.5 | 2.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.5 | 1.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.5 | 2.0 | GO:0060437 | lung growth(GO:0060437) |
| 0.5 | 0.5 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
| 0.5 | 0.5 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
| 0.5 | 4.6 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
| 0.5 | 1.5 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.5 | 1.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.5 | 4.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.5 | 5.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 | 15.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.5 | 4.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 | 3.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.5 | 2.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.5 | 2.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.5 | 1.5 | GO:1904828 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 0.5 | 5.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.5 | 1.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.5 | 1.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.5 | 2.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.5 | 1.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
| 0.5 | 13.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.5 | 9.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.5 | 1.4 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.5 | 2.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.5 | 4.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.5 | 1.0 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.5 | 2.9 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.5 | 1.9 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.5 | 2.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.5 | 1.4 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
| 0.5 | 0.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.5 | 0.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.5 | 0.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.5 | 2.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.5 | 1.9 | GO:0045186 | zonula adherens assembly(GO:0045186) |
| 0.5 | 2.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.5 | 1.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.5 | 1.8 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.5 | 0.5 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.5 | 6.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.5 | 1.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.5 | 0.9 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.5 | 0.9 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.5 | 2.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 | 2.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.5 | 2.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 | 1.3 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
| 0.4 | 1.8 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.4 | 4.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.4 | 5.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.4 | 1.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.4 | 2.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.4 | 4.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
| 0.4 | 0.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 0.4 | 1.8 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.4 | 0.9 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.4 | 3.5 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
| 0.4 | 3.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.4 | 8.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.4 | 3.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.4 | 10.8 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.4 | 3.5 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.4 | 0.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.4 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.4 | 0.4 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.4 | 6.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.4 | 2.6 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
| 0.4 | 3.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.4 | 7.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.4 | 4.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
| 0.4 | 0.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.4 | 1.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.4 | 1.7 | GO:0002086 | diaphragm contraction(GO:0002086) regulation of muscle filament sliding speed(GO:0032972) |
| 0.4 | 1.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.4 | 1.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.4 | 13.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.4 | 2.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.4 | 1.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 0.4 | 5.9 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.4 | 2.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.4 | 2.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.4 | 18.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.4 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.4 | 0.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.4 | 2.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.4 | 2.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 0.8 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.4 | 0.8 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.4 | 9.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.4 | 0.8 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 | 12.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.4 | 4.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.4 | 2.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.4 | 5.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.4 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.4 | 2.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.4 | 2.0 | GO:0090224 | regulation of spindle organization(GO:0090224) |
| 0.4 | 4.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 | 0.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.4 | 1.2 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.4 | 1.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.4 | 1.2 | GO:1990859 | cellular response to endothelin(GO:1990859) |
| 0.4 | 2.4 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.4 | 7.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.4 | 1.6 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.4 | 2.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.4 | 1.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.4 | 2.8 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.4 | 8.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.4 | 13.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.4 | 3.2 | GO:0015677 | copper ion import(GO:0015677) |
| 0.4 | 2.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.4 | 0.4 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.4 | 2.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.4 | 3.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.4 | 1.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.4 | 5.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.4 | 9.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.4 | 1.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.4 | 0.4 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 | 3.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.4 | 12.0 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.4 | 0.8 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
| 0.4 | 0.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.4 | 1.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 | 2.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.4 | 0.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.4 | 1.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
| 0.4 | 4.2 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.4 | 0.8 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 | 0.8 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.4 | 2.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.4 | 2.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.4 | 1.1 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.4 | 0.4 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.4 | 0.7 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.4 | 1.8 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.4 | 2.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.4 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
| 0.4 | 1.1 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
| 0.4 | 1.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.4 | 1.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.4 | 1.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.4 | 8.0 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.4 | 2.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.4 | 1.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.4 | 1.4 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.4 | 14.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.4 | 3.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.4 | 13.6 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.4 | 5.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.4 | 18.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.4 | 0.7 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
| 0.4 | 7.1 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.4 | 4.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.4 | 6.8 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.4 | 2.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.4 | 0.4 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.4 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.4 | 1.1 | GO:0046032 | ADP catabolic process(GO:0046032) IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.4 | 3.9 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.4 | 2.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.4 | 2.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.3 | 1.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 | 0.7 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
| 0.3 | 1.0 | GO:0019081 | viral translation(GO:0019081) |
| 0.3 | 1.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.3 | 0.7 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.3 | 2.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.3 | 5.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.3 | 2.1 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.3 | 3.4 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.3 | 1.0 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.3 | 1.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.3 | 0.7 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.3 | 2.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 5.5 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 2.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.3 | 3.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 2.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.3 | 3.0 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
| 0.3 | 1.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
| 0.3 | 1.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 2.3 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 5.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 | 2.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.3 | 2.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.3 | 7.4 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.3 | 3.6 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 0.3 | 3.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.3 | 9.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.3 | 3.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.3 | 2.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.3 | 1.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
| 0.3 | 3.2 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.3 | 2.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 | 1.6 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.3 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 2.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.3 | 3.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.3 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.3 | 0.6 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 | 3.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.3 | 0.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.3 | 1.2 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.3 | 3.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.3 | 0.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.3 | 1.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.3 | 0.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 1.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.3 | 0.9 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.3 | 1.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.3 | 0.9 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.3 | 1.5 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.3 | 3.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.3 | 0.6 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 | 1.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.3 | 1.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 1.2 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.3 | 1.2 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.3 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
| 0.3 | 1.4 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.3 | 3.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.3 | 2.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.3 | 0.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 0.3 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 | 0.9 | GO:0007494 | midgut development(GO:0007494) |
| 0.3 | 0.9 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.3 | 0.9 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.3 | 1.1 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.3 | 2.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 2.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.3 | 28.7 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.3 | 1.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.3 | 0.3 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.3 | 1.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 | 1.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.3 | 5.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.3 | 0.8 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
| 0.3 | 1.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 1.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.3 | 0.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.3 | 1.6 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.3 | 1.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.3 | 1.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.3 | 3.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.3 | 1.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 | 3.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 2.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.3 | 2.1 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
| 0.3 | 0.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.3 | 0.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 | 2.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.3 | 33.7 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.3 | 8.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.3 | 3.8 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.3 | 2.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.3 | 1.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 0.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 0.3 | 2.0 | GO:0031179 | peptide modification(GO:0031179) |
| 0.3 | 4.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.3 | 1.5 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.3 | 9.5 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 | 2.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 7.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.2 | 3.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 0.7 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 2.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 2.0 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.2 | 1.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.2 | 2.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 1.0 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.2 | 3.9 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.2 | 2.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
| 0.2 | 1.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 | 0.7 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
| 0.2 | 0.9 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
| 0.2 | 0.7 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.2 | 11.0 | GO:0061515 | myeloid cell development(GO:0061515) |
| 0.2 | 1.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 0.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.2 | 3.2 | GO:0007099 | centriole replication(GO:0007099) |
| 0.2 | 6.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.2 | 0.9 | GO:0042245 | RNA repair(GO:0042245) |
| 0.2 | 0.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 | 0.7 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
| 0.2 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 0.7 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.2 | 0.9 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 | 1.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
| 0.2 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.2 | 0.7 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
| 0.2 | 0.4 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.2 | 2.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.2 | 5.0 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.2 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 | 1.1 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
| 0.2 | 0.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 1.5 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 3.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.2 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.2 | 2.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
| 0.2 | 1.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.2 | 3.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.2 | 0.2 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
| 0.2 | 1.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 1.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.2 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.2 | 1.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.2 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 0.4 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.2 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.2 | 0.6 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.2 | 0.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 2.2 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
| 0.2 | 3.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.2 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.2 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 0.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
| 0.2 | 1.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 0.6 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.2 | 3.4 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 | 1.4 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.2 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.2 | 0.8 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 | 1.2 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 | 0.6 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.2 | 0.2 | GO:0090042 | tubulin deacetylation(GO:0090042) |
| 0.2 | 0.6 | GO:0035037 | sperm entry(GO:0035037) |
| 0.2 | 0.4 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.2 | 2.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.2 | 9.0 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 1.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 | 0.8 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.2 | 0.2 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.2 | 1.7 | GO:0030432 | peristalsis(GO:0030432) |
| 0.2 | 7.1 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.2 | 0.2 | GO:1904238 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
| 0.2 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 | 0.7 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.2 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 0.2 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.2 | 3.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.2 | 2.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.2 | 0.2 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.2 | 2.9 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 | 0.2 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.2 | 0.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.2 | 1.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) histone H3-R17 methylation(GO:0034971) |
| 0.2 | 0.2 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
| 0.2 | 5.9 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 | 0.5 | GO:0015867 | ATP transport(GO:0015867) |
| 0.2 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 | 0.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.2 | 2.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
| 0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.2 | 0.7 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.2 | 1.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.2 | 1.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 | 1.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 1.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 1.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 3.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.2 | 1.0 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.2 | 3.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.2 | 1.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.2 | 0.2 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.2 | 0.3 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.2 | 2.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.2 | 3.7 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.2 | 0.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.2 | 0.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.2 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 2.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.2 | 6.5 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
| 0.2 | 2.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 0.5 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.4 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
| 0.1 | 8.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.1 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 0.6 | GO:0043602 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.1 | 1.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.1 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 | 2.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
| 0.1 | 3.1 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.1 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.6 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.4 | GO:0015881 | creatine transport(GO:0015881) |
| 0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
| 0.1 | 2.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 | 7.5 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.1 | 0.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.1 | 0.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 2.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 0.4 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 | 0.3 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 | 2.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.4 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 | 0.9 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 | 0.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 | 0.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 | 1.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 | 0.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 1.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 | 0.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.1 | 0.1 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.1 | 1.7 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.1 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.1 | 0.4 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.1 | 0.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.5 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 1.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.7 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.1 | GO:2000232 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) regulation of rRNA processing(GO:2000232) |
| 0.1 | 1.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 0.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 | 0.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 2.5 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.1 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 | 4.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.1 | 1.0 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
| 0.1 | 2.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.1 | 8.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.1 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 0.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 0.1 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.1 | 1.7 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
| 0.1 | 0.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.1 | 3.5 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
| 0.1 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
| 0.1 | 0.4 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.4 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 0.7 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
| 0.1 | 0.4 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
| 0.1 | 1.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 1.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.1 | 0.9 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.1 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.1 | 0.3 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
| 0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
| 0.1 | 1.6 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.1 | 1.4 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 | 1.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 1.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.2 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
| 0.1 | 1.6 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
| 0.1 | 4.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.1 | 2.1 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
| 0.1 | 1.5 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.1 | 0.7 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.1 | 0.4 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
| 0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 0.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.1 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.1 | 1.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 0.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 | 1.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 0.8 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
| 0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.1 | 2.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.1 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 | 0.2 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 0.1 | 0.1 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.1 | 0.3 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 0.1 | 0.4 | GO:0033032 | myeloid cell apoptotic process(GO:0033028) regulation of myeloid cell apoptotic process(GO:0033032) |
| 0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.1 | 1.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.2 | GO:0031591 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 0.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 | 0.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.0 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.0 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.0 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 10.9 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.0 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.0 | 0.6 | GO:0051181 | cofactor transport(GO:0051181) |
| 0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.0 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 | 0.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 | 0.1 | GO:0061744 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.0 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.0 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.0 | 0.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.0 | 4.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.0 | 0.1 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.0 | 0.2 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.0 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.0 | 0.3 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 0.0 | 0.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.0 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.0 | 0.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.1 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.0 | 0.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.0 | 0.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.0 | 0.0 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.0 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.2 | 44.8 | GO:0001740 | Barr body(GO:0001740) |
| 6.5 | 19.6 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
| 5.6 | 33.5 | GO:0031523 | Myb complex(GO:0031523) |
| 4.9 | 19.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 4.5 | 17.9 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 4.5 | 35.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 4.4 | 13.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 4.1 | 12.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 4.0 | 15.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 3.8 | 30.5 | GO:0008091 | spectrin(GO:0008091) |
| 3.4 | 13.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 3.4 | 3.4 | GO:0035061 | interchromatin granule(GO:0035061) |
| 3.3 | 16.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 3.3 | 23.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 3.1 | 18.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 3.0 | 27.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 2.9 | 11.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 2.8 | 19.4 | GO:0005638 | lamin filament(GO:0005638) |
| 2.7 | 22.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 2.7 | 43.9 | GO:0042555 | MCM complex(GO:0042555) |
| 2.7 | 13.6 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 2.7 | 32.0 | GO:0000796 | condensin complex(GO:0000796) |
| 2.5 | 15.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 2.5 | 10.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 2.5 | 7.4 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 2.4 | 7.3 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 2.4 | 7.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 2.3 | 7.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 2.3 | 9.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 2.3 | 11.5 | GO:0071953 | elastic fiber(GO:0071953) |
| 2.3 | 22.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 2.3 | 38.3 | GO:0001939 | female pronucleus(GO:0001939) |
| 2.1 | 20.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 2.1 | 6.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 2.0 | 20.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 2.0 | 6.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.9 | 18.7 | GO:0042382 | paraspeckles(GO:0042382) |
| 1.9 | 13.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 1.9 | 9.3 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.9 | 5.6 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.8 | 5.5 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.8 | 12.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.8 | 10.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 1.8 | 5.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 1.8 | 12.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 1.8 | 15.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 1.7 | 18.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 1.7 | 5.0 | GO:0000235 | astral microtubule(GO:0000235) |
| 1.6 | 24.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 1.6 | 4.9 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 1.6 | 25.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.6 | 1.6 | GO:0035101 | FACT complex(GO:0035101) |
| 1.6 | 4.7 | GO:1990423 | RZZ complex(GO:1990423) |
| 1.6 | 6.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 1.5 | 7.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 1.5 | 9.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 1.5 | 1.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.5 | 8.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 1.5 | 10.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 1.5 | 4.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 1.5 | 22.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.5 | 8.8 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 1.5 | 4.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.4 | 2.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 1.4 | 4.2 | GO:0044308 | axonal spine(GO:0044308) |
| 1.4 | 11.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.4 | 8.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 1.3 | 20.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 1.3 | 14.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 1.3 | 73.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 1.3 | 36.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 1.3 | 6.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 1.3 | 13.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 1.3 | 41.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.3 | 15.6 | GO:0008278 | cohesin complex(GO:0008278) |
| 1.3 | 1.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
| 1.3 | 7.7 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 1.3 | 5.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 1.3 | 6.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 1.3 | 8.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 1.3 | 6.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.2 | 2.5 | GO:0000974 | Prp19 complex(GO:0000974) |
| 1.2 | 3.7 | GO:0031904 | endosome lumen(GO:0031904) |
| 1.2 | 4.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 1.2 | 2.4 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
| 1.2 | 4.8 | GO:0043511 | inhibin complex(GO:0043511) |
| 1.2 | 18.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 1.2 | 8.3 | GO:0005955 | calcineurin complex(GO:0005955) |
| 1.2 | 3.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 1.2 | 21.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 1.2 | 2.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 1.2 | 1.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 1.1 | 8.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.1 | 22.7 | GO:0031143 | pseudopodium(GO:0031143) |
| 1.1 | 10.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.1 | 28.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 1.1 | 3.3 | GO:1990879 | CST complex(GO:1990879) |
| 1.1 | 11.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.1 | 3.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 1.0 | 13.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.0 | 12.5 | GO:0034709 | methylosome(GO:0034709) |
| 1.0 | 4.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 1.0 | 10.4 | GO:0000322 | storage vacuole(GO:0000322) |
| 1.0 | 9.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.0 | 6.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 1.0 | 5.1 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.0 | 10.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 1.0 | 4.1 | GO:0008623 | CHRAC(GO:0008623) |
| 1.0 | 3.0 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 1.0 | 5.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 1.0 | 4.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 1.0 | 3.8 | GO:0071920 | cleavage body(GO:0071920) |
| 0.9 | 2.8 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 0.9 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.9 | 0.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.9 | 4.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.9 | 38.6 | GO:0002102 | podosome(GO:0002102) |
| 0.9 | 1.8 | GO:0042585 | germinal vesicle(GO:0042585) |
| 0.9 | 16.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.9 | 28.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.9 | 4.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.8 | 9.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.8 | 2.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.8 | 2.5 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.8 | 0.8 | GO:0097433 | dense body(GO:0097433) |
| 0.8 | 5.0 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.8 | 12.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.8 | 6.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.8 | 27.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.8 | 14.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.8 | 4.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.8 | 2.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.8 | 11.3 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.8 | 7.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.8 | 13.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.8 | 4.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.8 | 10.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.8 | 9.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.8 | 15.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.8 | 17.0 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.8 | 2.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.8 | 14.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.8 | 15.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.8 | 13.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.8 | 38.4 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.8 | 5.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.7 | 6.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.7 | 0.7 | GO:0000805 | X chromosome(GO:0000805) |
| 0.7 | 5.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.7 | 2.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.7 | 6.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.7 | 4.4 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.7 | 2.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 0.7 | 1.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.7 | 2.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.7 | 6.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.7 | 8.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.7 | 4.2 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.7 | 2.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.7 | 5.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.7 | 53.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.7 | 4.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.7 | 2.1 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.7 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.7 | 25.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.7 | 8.1 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.7 | 54.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.7 | 18.5 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.7 | 1.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.7 | 4.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.7 | 1.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.6 | 5.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.6 | 4.5 | GO:0098536 | deuterosome(GO:0098536) |
| 0.6 | 5.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.6 | 2.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.6 | 1.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.6 | 3.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.6 | 1.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.6 | 2.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.6 | 4.3 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 0.6 | 2.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.6 | 30.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.6 | 3.0 | GO:0070449 | elongin complex(GO:0070449) |
| 0.6 | 22.8 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.6 | 33.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.6 | 1.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.6 | 64.0 | GO:0016605 | PML body(GO:0016605) |
| 0.6 | 9.9 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.6 | 4.1 | GO:0030689 | Noc complex(GO:0030689) |
| 0.6 | 24.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.6 | 4.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.6 | 31.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.6 | 14.7 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.6 | 16.2 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.5 | 37.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.5 | 1.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.5 | 4.3 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.5 | 1.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.5 | 6.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.5 | 2.6 | GO:0043293 | apoptosome(GO:0043293) |
| 0.5 | 10.9 | GO:0005605 | basal lamina(GO:0005605) |
| 0.5 | 4.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.5 | 28.9 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.5 | 7.7 | GO:0010369 | chromocenter(GO:0010369) |
| 0.5 | 5.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.5 | 5.1 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.5 | 90.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.5 | 4.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.5 | 32.1 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.5 | 3.0 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.5 | 2.0 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.5 | 7.4 | GO:0071437 | invadopodium(GO:0071437) |
| 0.5 | 1.9 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 4.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.5 | 5.2 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.5 | 7.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.5 | 2.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.5 | 8.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.5 | 1.4 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
| 0.5 | 4.6 | GO:0031415 | NatA complex(GO:0031415) |
| 0.5 | 42.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.5 | 57.6 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.5 | 10.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.5 | 9.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.4 | 3.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.4 | 5.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.4 | 0.9 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
| 0.4 | 5.8 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.4 | 7.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.4 | 3.9 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.4 | 3.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.4 | 7.3 | GO:0000791 | euchromatin(GO:0000791) |
| 0.4 | 9.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.4 | 3.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.4 | 19.2 | GO:0016592 | mediator complex(GO:0016592) |
| 0.4 | 5.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.4 | 12.2 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.4 | 3.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.4 | 4.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.4 | 12.5 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.4 | 25.6 | GO:0000922 | spindle pole(GO:0000922) |
| 0.4 | 1.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.4 | 1.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.4 | 1.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.4 | 10.3 | GO:0015030 | Cajal body(GO:0015030) |
| 0.4 | 0.4 | GO:0044753 | amphisome(GO:0044753) |
| 0.4 | 39.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.4 | 27.9 | GO:0005814 | centriole(GO:0005814) |
| 0.4 | 4.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.4 | 37.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.3 | 2.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 3.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 4.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.3 | 20.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.3 | 29.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.3 | 2.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.3 | 2.7 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.3 | 2.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.3 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 15.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.3 | 0.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.3 | 1.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.3 | 5.4 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.3 | 0.9 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.3 | 3.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.3 | 5.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 17.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.3 | 2.5 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.3 | 1.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.3 | 3.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.3 | 17.0 | GO:0005819 | spindle(GO:0005819) |
| 0.3 | 2.9 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.3 | 8.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.3 | 3.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.3 | 4.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 2.0 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.3 | 4.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.3 | 3.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.3 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 2.0 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.3 | 2.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.3 | 3.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.3 | 6.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.3 | 2.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.3 | 4.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.3 | 3.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 12.2 | GO:0030496 | midbody(GO:0030496) |
| 0.3 | 3.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 2.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.3 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.2 | 1.0 | GO:0071547 | piP-body(GO:0071547) |
| 0.2 | 1.7 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.2 | 3.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.2 | 0.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 1.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.2 | 1.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.2 | 1.2 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 4.4 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.2 | 6.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 6.7 | GO:0030904 | retromer complex(GO:0030904) |
| 0.2 | 0.5 | GO:0033202 | DNA helicase complex(GO:0033202) |
| 0.2 | 4.1 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 0.9 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.2 | 6.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.2 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.2 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 1.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.2 | 0.6 | GO:0090537 | CERF complex(GO:0090537) |
| 0.2 | 0.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 1.5 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 1.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 2.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 3.1 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 0.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.2 | 1.2 | GO:0045120 | pronucleus(GO:0045120) |
| 0.2 | 1.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.2 | 3.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 40.8 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.2 | 0.9 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
| 0.2 | 4.8 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 0.2 | 0.7 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.2 | 0.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 4.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.2 | 1.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 3.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.2 | 1.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.2 | 7.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.2 | 2.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 2.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 4.3 | GO:0005884 | actin filament(GO:0005884) |
| 0.2 | 1.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.2 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.2 | 1.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 8.5 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 0.5 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.2 | 40.1 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 1.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 2.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 23.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 1.3 | GO:1990752 | microtubule end(GO:1990752) |
| 0.1 | 1.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.6 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.1 | 7.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.1 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 0.7 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 3.9 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 1.4 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 2.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 1.2 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 2.8 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.1 | 2.4 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 2.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 1.3 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 0.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.1 | 2.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 0.1 | 7.5 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.1 | 2.0 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 6.0 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 1.1 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 19.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 48.5 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 0.3 | GO:0000803 | sex chromosome(GO:0000803) |
| 0.1 | 3.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 20.7 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
| 0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 8.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 1.0 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 1.3 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.6 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 1.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.0 | 1.7 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 0.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.0 | 7.7 | GO:0005694 | chromosome(GO:0005694) |
| 0.0 | 0.1 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.0 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 6.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.4 | 16.1 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
| 5.2 | 15.6 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 5.2 | 31.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 5.0 | 15.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 4.9 | 4.9 | GO:0034046 | poly(G) binding(GO:0034046) |
| 4.9 | 24.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 4.7 | 14.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 4.7 | 14.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 4.3 | 12.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 4.1 | 36.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 4.0 | 4.0 | GO:0031692 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
| 3.9 | 11.6 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
| 3.8 | 3.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 3.8 | 18.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 3.7 | 18.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 3.5 | 21.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 3.3 | 10.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 2.7 | 16.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 2.7 | 8.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 2.7 | 8.0 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 2.6 | 13.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 2.6 | 10.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 2.6 | 13.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 2.6 | 51.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 2.6 | 7.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 2.5 | 22.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 2.5 | 9.8 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 2.4 | 7.2 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 2.4 | 7.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 2.4 | 7.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 2.4 | 14.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 2.3 | 25.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 2.3 | 9.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 2.3 | 6.8 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 2.2 | 6.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 2.2 | 91.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 2.2 | 6.5 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 2.2 | 10.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 2.1 | 15.0 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 2.1 | 8.5 | GO:0030519 | snoRNP binding(GO:0030519) |
| 2.1 | 2.1 | GO:0070540 | stearic acid binding(GO:0070540) |
| 2.1 | 10.6 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 2.1 | 6.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 2.1 | 24.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 2.0 | 34.5 | GO:0005522 | profilin binding(GO:0005522) |
| 2.0 | 6.1 | GO:0003896 | DNA primase activity(GO:0003896) |
| 2.0 | 18.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 2.0 | 2.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 2.0 | 7.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.9 | 5.8 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 1.9 | 9.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.9 | 1.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 1.8 | 20.3 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
| 1.8 | 5.5 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 1.8 | 74.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 1.8 | 3.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 1.8 | 5.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 1.8 | 17.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.8 | 12.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 1.8 | 19.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 1.8 | 5.3 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
| 1.7 | 3.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 1.7 | 16.9 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.7 | 10.1 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.7 | 5.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 1.7 | 26.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 1.7 | 29.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 1.6 | 1.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.6 | 11.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 1.6 | 21.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 1.5 | 3.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.5 | 4.6 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 1.5 | 9.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 1.5 | 4.5 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 1.5 | 4.4 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 1.5 | 4.4 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
| 1.5 | 35.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 1.5 | 3.0 | GO:0048030 | disaccharide binding(GO:0048030) |
| 1.5 | 10.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 1.5 | 23.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 1.5 | 5.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 1.4 | 4.3 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 1.4 | 42.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 1.4 | 17.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 1.4 | 40.9 | GO:0008143 | poly(A) binding(GO:0008143) |
| 1.4 | 11.2 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
| 1.4 | 5.6 | GO:0031013 | troponin I binding(GO:0031013) |
| 1.4 | 25.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 1.4 | 6.9 | GO:1990188 | euchromatin binding(GO:1990188) |
| 1.4 | 29.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 1.4 | 4.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.4 | 8.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 1.4 | 20.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 1.4 | 4.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 1.4 | 12.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.3 | 8.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 1.3 | 4.0 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 1.3 | 4.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 1.3 | 4.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.3 | 5.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 1.3 | 18.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 1.3 | 20.8 | GO:0051861 | glycolipid binding(GO:0051861) |
| 1.3 | 7.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.3 | 3.9 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
| 1.3 | 6.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.3 | 7.7 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 1.3 | 15.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.3 | 6.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 1.3 | 5.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 1.3 | 1.3 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 1.3 | 3.8 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
| 1.3 | 5.0 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 1.2 | 5.0 | GO:0070976 | TIR domain binding(GO:0070976) |
| 1.2 | 3.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 1.2 | 6.2 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.2 | 61.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 1.2 | 34.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 1.2 | 10.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 1.2 | 10.9 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 1.2 | 3.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 1.2 | 3.6 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 1.2 | 3.6 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
| 1.2 | 4.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 1.2 | 8.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 1.2 | 5.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 1.2 | 3.5 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 1.2 | 11.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 1.1 | 6.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.1 | 6.8 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
| 1.1 | 18.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 1.1 | 14.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 1.1 | 6.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 1.1 | 3.3 | GO:0035939 | microsatellite binding(GO:0035939) |
| 1.1 | 4.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 1.1 | 3.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 1.1 | 8.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.1 | 4.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 1.1 | 1.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 1.1 | 10.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 1.1 | 4.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 1.1 | 3.2 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 1.1 | 5.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 1.1 | 6.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 1.1 | 3.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 1.1 | 9.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 1.0 | 4.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.0 | 4.2 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
| 1.0 | 7.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 1.0 | 51.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 1.0 | 10.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 1.0 | 7.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 1.0 | 31.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 1.0 | 12.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 1.0 | 1.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.0 | 5.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 1.0 | 7.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 1.0 | 9.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 1.0 | 6.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 1.0 | 12.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 1.0 | 13.0 | GO:1990405 | protein antigen binding(GO:1990405) |
| 1.0 | 3.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 1.0 | 32.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 1.0 | 146.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 1.0 | 5.9 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 1.0 | 4.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 1.0 | 8.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.0 | 27.4 | GO:0070840 | dynein complex binding(GO:0070840) |
| 1.0 | 3.9 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 1.0 | 4.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 1.0 | 2.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 1.0 | 22.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.9 | 25.5 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.9 | 2.8 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.9 | 2.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.9 | 3.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.9 | 2.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.9 | 1.8 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 0.9 | 7.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.9 | 3.6 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.9 | 2.7 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.9 | 18.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.9 | 2.6 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 0.9 | 3.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.9 | 5.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.9 | 0.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.9 | 7.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.9 | 3.5 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
| 0.9 | 6.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.9 | 5.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.9 | 31.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.9 | 28.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.9 | 5.2 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.9 | 8.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.8 | 4.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.8 | 9.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.8 | 0.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.8 | 5.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.8 | 2.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.8 | 3.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.8 | 1.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.8 | 8.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.8 | 17.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.8 | 3.2 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
| 0.8 | 5.6 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.8 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.8 | 36.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.8 | 7.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.8 | 0.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.8 | 2.4 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.8 | 18.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.8 | 2.3 | GO:0001729 | ceramide kinase activity(GO:0001729) |
| 0.8 | 7.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.8 | 4.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 0.8 | 3.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.8 | 1.5 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.8 | 12.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.8 | 10.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.8 | 5.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.8 | 3.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.7 | 47.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.7 | 6.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.7 | 6.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.7 | 11.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.7 | 11.0 | GO:0005536 | glucose binding(GO:0005536) |
| 0.7 | 2.2 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.7 | 6.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.7 | 8.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.7 | 2.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.7 | 11.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.7 | 2.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.7 | 3.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.7 | 3.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.7 | 9.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.7 | 2.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.7 | 6.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.7 | 4.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.7 | 3.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.7 | 3.4 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.7 | 4.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.7 | 36.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.7 | 4.0 | GO:0070728 | leucine binding(GO:0070728) |
| 0.7 | 2.0 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
| 0.7 | 1.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.7 | 4.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.7 | 4.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.7 | 4.0 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.7 | 4.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.7 | 2.0 | GO:0019978 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
| 0.7 | 7.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.7 | 2.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.7 | 14.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.7 | 2.6 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.7 | 3.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.7 | 3.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.6 | 1.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.6 | 5.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.6 | 29.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.6 | 3.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.6 | 16.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.6 | 1.9 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
| 0.6 | 7.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.6 | 2.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.6 | 2.5 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.6 | 3.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.6 | 4.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.6 | 1.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.6 | 3.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.6 | 1.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.6 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.6 | 6.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.6 | 9.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.6 | 17.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.6 | 7.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.6 | 3.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.6 | 2.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.6 | 3.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.6 | 13.3 | GO:0005521 | lamin binding(GO:0005521) |
| 0.6 | 2.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.6 | 30.8 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.6 | 5.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.6 | 2.8 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.6 | 3.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.6 | 6.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.6 | 3.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.5 | 3.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.5 | 9.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.5 | 1.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.5 | 0.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.5 | 2.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.5 | 3.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.5 | 12.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.5 | 40.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.5 | 12.6 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.5 | 11.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.5 | 2.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.5 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.5 | 8.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.5 | 1.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.5 | 2.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.5 | 15.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.5 | 2.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.5 | 2.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.5 | 4.0 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.5 | 5.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.5 | 1.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.5 | 13.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.5 | 3.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.5 | 43.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.5 | 2.5 | GO:0005113 | patched binding(GO:0005113) |
| 0.5 | 2.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.5 | 5.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.5 | 12.5 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.5 | 9.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.5 | 20.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.5 | 1.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.5 | 4.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.5 | 34.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.5 | 2.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.5 | 0.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.5 | 10.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.5 | 5.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.5 | 2.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.5 | 6.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.5 | 14.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.5 | 9.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 28.3 | GO:0070888 | E-box binding(GO:0070888) |
| 0.4 | 2.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.4 | 1.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.4 | 5.8 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.4 | 1.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.4 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.4 | 2.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.4 | 1.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.4 | 3.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.4 | 22.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.4 | 1.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.4 | 10.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.4 | 2.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 1.7 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.4 | 24.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.4 | 2.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.4 | 3.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.4 | 2.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.4 | 5.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.4 | 19.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.4 | 68.4 | GO:0042393 | histone binding(GO:0042393) |
| 0.4 | 1.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.4 | 1.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.4 | 1.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.4 | 7.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.4 | 2.4 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.4 | 4.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.4 | 1.6 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.4 | 2.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.4 | 2.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.4 | 0.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.4 | 2.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.4 | 3.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.4 | 66.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.4 | 2.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.4 | 2.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.4 | 0.8 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.4 | 3.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.4 | 6.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.4 | 5.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.4 | 1.9 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 2.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.4 | 1.5 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.4 | 7.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.4 | 1.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.4 | 3.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.4 | 6.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.4 | 1.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
| 0.4 | 0.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
| 0.4 | 1.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.4 | 1.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.4 | 1.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.4 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.4 | 1.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.4 | 2.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.4 | 12.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 1.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.4 | 2.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.4 | 21.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.3 | 0.7 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.3 | 2.4 | GO:0070990 | snRNP binding(GO:0070990) |
| 0.3 | 22.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.3 | 2.1 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 0.3 | 2.4 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.3 | 0.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.3 | 1.0 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 1.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.3 | 3.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 0.3 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.3 | 3.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 3.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.3 | 17.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.3 | 1.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.3 | 2.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.3 | 2.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.3 | 3.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 2.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 1.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.3 | 1.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.3 | 8.4 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.3 | 1.6 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 0.3 | 1.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.3 | 4.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.3 | 14.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.3 | 2.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.3 | 2.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.3 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.3 | 0.9 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 4.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 11.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.3 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 2.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.3 | 0.9 | GO:1990931 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
| 0.3 | 1.2 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.3 | 5.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.3 | 0.9 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.3 | 2.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 1.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.3 | 0.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.3 | 20.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.3 | 1.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
| 0.3 | 3.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.3 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.3 | 1.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.3 | 1.2 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.3 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.3 | 2.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.3 | 1.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 0.8 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.3 | 2.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 0.8 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.3 | 0.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 6.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.3 | 3.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.3 | 1.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.3 | 1.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.3 | 3.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.3 | 0.8 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.3 | 0.5 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.3 | 3.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.3 | 1.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.3 | 0.5 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.3 | 1.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.3 | 1.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.3 | 3.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.3 | 0.3 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
| 0.3 | 0.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.3 | 0.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.3 | 9.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.3 | 2.3 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
| 0.3 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 1.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.3 | 1.0 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
| 0.2 | 1.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.2 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.2 | 1.0 | GO:0051435 | BH4 domain binding(GO:0051435) |
| 0.2 | 14.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 3.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 4.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 2.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.2 | 1.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.2 | 0.7 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 0.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 0.9 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.2 | 0.7 | GO:0018169 | ribosomal S6-glutamic acid ligase activity(GO:0018169) |
| 0.2 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 2.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 4.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.2 | 0.9 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 0.6 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.2 | 0.6 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.2 | 7.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.2 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 11.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 3.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 36.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 7.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.2 | 0.6 | GO:0008456 | alpha-N-acetylgalactosaminidase activity(GO:0008456) |
| 0.2 | 4.2 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.2 | 5.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.2 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 0.8 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
| 0.2 | 1.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 0.8 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.2 | 1.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 1.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 2.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.2 | 1.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.2 | 0.7 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.2 | 7.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 0.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.2 | 0.5 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.2 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 8.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 15.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.2 | 21.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 25.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.2 | 1.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 1.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.2 | 0.3 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.2 | 10.0 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.2 | 230.3 | GO:0003723 | RNA binding(GO:0003723) |
| 0.2 | 0.5 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
| 0.2 | 0.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.2 | 0.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 5.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 3.5 | GO:0010181 | FMN binding(GO:0010181) |
| 0.2 | 8.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 1.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 4.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.2 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 0.6 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 0.1 | 2.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.1 | 0.4 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 1.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 0.7 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 0.4 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.1 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 5.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 3.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.1 | 5.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.1 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
| 0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.1 | 0.2 | GO:0036004 | GAF domain binding(GO:0036004) |
| 0.1 | 0.9 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.1 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 0.4 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
| 0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 2.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 0.5 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.1 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
| 0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 1.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 0.7 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 0.3 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
| 0.1 | 0.2 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
| 0.1 | 13.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) vascular endothelial growth factor binding(GO:0038085) |
| 0.1 | 0.5 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.1 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.1 | 21.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.1 | 0.2 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.1 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
| 0.1 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.1 | 0.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 1.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 2.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.1 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.1 | 0.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.1 | 0.6 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.0 | 0.1 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
| 0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.0 | 0.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.0 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.0 | 0.1 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.0 | 2.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.3 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.0 | 0.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.0 | 0.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.0 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
| 0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.0 | 0.1 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.0 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 2.6 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
| 0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.0 | 0.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.0 | 0.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.0 | 0.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 2.0 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 71.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 2.4 | 24.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 2.4 | 11.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 2.0 | 2.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 1.8 | 101.5 | PID AURORA B PATHWAY | Aurora B signaling |
| 1.6 | 94.4 | PID PLK1 PATHWAY | PLK1 signaling events |
| 1.5 | 72.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 1.5 | 61.1 | PID ATR PATHWAY | ATR signaling pathway |
| 1.4 | 179.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 1.3 | 108.8 | PID E2F PATHWAY | E2F transcription factor network |
| 1.3 | 72.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 1.2 | 36.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 1.2 | 14.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 1.2 | 63.1 | PID IGF1 PATHWAY | IGF1 pathway |
| 1.1 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 1.1 | 69.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 1.1 | 23.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 1.1 | 25.6 | PID ATM PATHWAY | ATM pathway |
| 1.0 | 19.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.9 | 11.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.9 | 6.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.9 | 14.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.9 | 1.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.9 | 29.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.8 | 33.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.8 | 47.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.8 | 12.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.8 | 48.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.8 | 42.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.8 | 18.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.8 | 72.9 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.8 | 22.6 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.7 | 48.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.7 | 5.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.7 | 2.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.7 | 1.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.6 | 4.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.6 | 10.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.6 | 54.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.6 | 4.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.6 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.6 | 4.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.6 | 14.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.6 | 2.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.6 | 3.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.6 | 11.6 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.6 | 6.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.5 | 14.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.5 | 3.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.5 | 13.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.5 | 6.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.5 | 7.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.5 | 19.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.5 | 10.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.5 | 5.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.4 | 18.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.4 | 11.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.4 | 2.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.4 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.4 | 2.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.4 | 26.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.4 | 1.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.4 | 2.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.4 | 6.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.4 | 2.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.4 | 31.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.4 | 12.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.4 | 5.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.4 | 5.4 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.4 | 7.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.4 | 7.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.4 | 5.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.4 | 23.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.3 | 2.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 1.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 6.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.3 | 14.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.3 | 19.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.3 | 19.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.3 | 6.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.3 | 26.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.3 | 14.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.3 | 3.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.3 | 5.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.3 | 3.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.3 | 6.8 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 4.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 3.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.2 | 5.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 2.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 5.1 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 4.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 3.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 6.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.2 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 4.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 3.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 3.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.2 | 8.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.2 | 2.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.2 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.2 | 6.0 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 2.8 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.1 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 6.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 11.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 22.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 3.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 1.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 8.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 1.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 1.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 2.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 1.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.8 | 40.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 4.9 | 78.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 3.9 | 7.8 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
| 3.8 | 91.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 3.3 | 48.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 3.1 | 44.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 3.1 | 39.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 3.0 | 59.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 2.8 | 62.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 2.6 | 46.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 2.5 | 5.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 2.2 | 22.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 2.1 | 22.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 1.9 | 13.6 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 1.9 | 26.3 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 1.9 | 72.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 1.8 | 79.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 1.7 | 35.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 1.5 | 42.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 1.4 | 5.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 1.4 | 51.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 1.3 | 57.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 1.3 | 28.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 1.2 | 21.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 1.2 | 1.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 1.2 | 28.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 1.2 | 37.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.1 | 50.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 1.1 | 26.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 1.1 | 29.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 1.0 | 6.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.0 | 16.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 1.0 | 10.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.9 | 33.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.9 | 7.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.9 | 10.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.9 | 24.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.9 | 73.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.9 | 14.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.9 | 15.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.9 | 1.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.8 | 63.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.8 | 18.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.8 | 107.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.8 | 19.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.8 | 7.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.8 | 9.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.7 | 9.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.7 | 81.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.7 | 3.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.7 | 12.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.7 | 14.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.7 | 9.1 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
| 0.7 | 31.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.7 | 20.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.7 | 16.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.6 | 8.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.6 | 1.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.6 | 5.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.6 | 25.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.6 | 35.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.6 | 40.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.6 | 5.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.6 | 10.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.6 | 10.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.6 | 2.4 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.6 | 12.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.6 | 9.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.6 | 8.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.6 | 4.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.5 | 9.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.5 | 19.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.5 | 21.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.5 | 12.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.5 | 26.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.5 | 2.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.5 | 45.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.5 | 3.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.5 | 13.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.5 | 8.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.5 | 9.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.5 | 6.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.5 | 8.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.5 | 5.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.5 | 9.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.5 | 7.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.5 | 12.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.5 | 13.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.4 | 6.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.4 | 2.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.4 | 18.9 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.4 | 3.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.4 | 33.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.4 | 47.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.4 | 16.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.4 | 3.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.4 | 3.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.4 | 4.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 25.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.4 | 11.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.4 | 5.7 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.4 | 4.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.4 | 6.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.4 | 24.6 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.4 | 0.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.3 | 5.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.3 | 9.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.3 | 20.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.3 | 8.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.3 | 29.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.3 | 7.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.3 | 3.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.3 | 3.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.3 | 0.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.3 | 5.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.3 | 7.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.3 | 3.8 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
| 0.3 | 1.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.3 | 2.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.2 | 4.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 1.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 3.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 12.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.2 | 3.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 4.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 8.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 5.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.2 | 0.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.2 | 1.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.2 | 54.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.2 | 3.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.2 | 2.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.2 | 2.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 3.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 3.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.2 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 2.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 4.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 1.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.1 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 1.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 1.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 2.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.0 | 1.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
| 0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |